Home » Posts tagged with » Coronavirus
Gilead Sciences bags Remdesivir FDA approval for Covid-19 treatment

Gilead Sciences bags Remdesivir FDA approval for Covid-19 treatment

Remdesivir FDA approval : Gilead Sciences, a California-based biopharma company, has bagged approval from the US Food and Drug Administration (FDA) for its antiviral drug Veklury (remdesivir) for Covid-19 treatment in patients requiring hospitalization. This makes remdesivir the first approved treatment for coronavirus in the US. Remdesivir FDA approved indication : Veklury has been approved […]

AstraZeneca to advance AZD7442 into phase 3 Covid-19 trials

AstraZeneca said that AZD7442, which is being developed for the prevention and treatment of Covid-19, will move into two phase 3 clinical trials. AZD7442 is a combination of a couple of monoclonal antibodies (mAbs) extracted from convalescent patients with SARS-CoV-2 infection. It will be assessed in more than 6,000 participants at sites in and outside […]

Continue reading …
VirTrial to help BetterLife Pharma in launching COVID-19 clinical trials

VirTrial, a US bioscience technology company, has been selected by Canadian biotech company BetterLife Pharma as its telehealth platform provider of choice for launching COVID-19 clinical trials. The partnership will help BetterLife Pharma to carry out remote patient monitoring for its upcoming COVID-19 clinical trials in Australia for evaluating the efficacy of its interferon alpha 2b formulation […]

Continue reading …
EC strikes deal for supply of JNJ-78436735 Covid-19 vaccine candidate

Johnson & Johnson (J&J) said that the European Commission (EC) has approved an advance purchase agreement for securing 200 million doses of the JNJ-78436735 Covid-19 vaccine candidate (Ad26.COV2.S) developed by its subsidiary Janssen Pharmaceutical Companies. Currently, the JNJ-78436735 vaccine candidate is being evaluated in the phase 3 ENSEMBLE Covid-19 vaccine trial across certain countries. The […]

Continue reading …
Noxopharm doses first patient in NOXCOVID-1 clinical trial with Veyonda

Australian drug development company Noxopharm has dosed the first patient in the phase 1 NOXCOVID-1 clinical trial with Veyonda, its lead pipeline candidate, in hospitalized COVID-19 patients. Veyonda is an experimental anti-cancer drug. It is being evaluated in the NOXCOVID-1 clinical trial in the treatment of hospitalized patients with moderate lung dysfunction, who need low […]

Continue reading …
Dr. Reddy’s, RDIF to bring Sputnik V coronavirus vaccine to India

Russian Direct Investment Fund (RDIF) and Dr. Reddy’s Laboratories have agreed to cooperate on clinical trials and distribution of the Sputnik V coronavirus vaccine in India. After receiving regulatory approval in India, the Russian sovereign wealth fund will supply 100 million doses of the vaccine to Dr. Reddy’s. The Sputnik V coronavirus vaccine, which is […]

Continue reading …
SAB Biotherapeutics begins phase 1b Covid-19 trial of SAB-185

SAB Biotherapeutics, a US biopharma company, said that the first patient in a phase 1b clinical trial of its investigational Covid-19 therapeutic SAB-185 has been dosed. The early-stage trial is assessing the safety and pharmacological activity of SAB-185 in Covid-19 patients. SAB-185, which was generated from a subunit of the SARS-CoV-2 Wuhan strain, has delivered […]

Continue reading …
Northway Biotechpharma to manufacture Memo’s Covid1-9 drug MTX-COVAB

Memo Therapeutics (MTx), a Swiss biotech company, has entered into a partnership with Northway Biotechpharma, under which the latter will manufacture the former’s MTX-COVAB – a COVID-19 antibody candidate in a four-month fast-track process. Northway Biotechpharma is a biopharmaceutical contract development and manufacturing organization (CDMO) based in Lithuania. MTX-COVAB, which is the lead antibody candidate […]

Continue reading …
Moderna bags $1.5bn contract to supply mRNA-1273 Covid-19 vaccine to US govt

Moderna has bagged a deal worth up to $1.52 billion for the manufacturing and supply of 100 million doses of its mRNA-1273 vaccine candidate for Covid-19 to the US government. The US biotech company said that the award for the mRNA vaccine candidate includes incentive payments for the timely supply of the product. As per […]

Continue reading …
Pfizer to manufacture Gilead’s Covid-19 drug candidate remdesivir

Pfizer has signed a multi-year agreement with Gilead Sciences to manufacture and supply the latter’s investigational antiviral remdesivir for the treatment of Covid-19. Under the deal terms, Pfizer will offer contract manufacturing services at its McPherson, Kansas facility for the manufacture and supply of remdesivir. Earlier this year, Pfizer came out with a five-point plan, […]

Continue reading …
Page 1 of 9123Next ›Last »